|
MAFG expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.53581999999819E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.43959988164033E-10 |
| Normal-vs-Stage2 |
1.089200E-01 |
| Normal-vs-Stage3 |
6.337600E-01 |
| Normal-vs-Stage4 |
2.989400E-01 |
| Stage1-vs-Stage2 |
5.477800E-02 |
| Stage1-vs-Stage3 |
2.36170000000868E-07 |
| Stage1-vs-Stage4 |
6.02079999999505E-05 |
| Stage2-vs-Stage3 |
2.037000E-01 |
| Stage2-vs-Stage4 |
3.919800E-01 |
| Stage3-vs-Stage4 |
5.799800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.002600E-04 |
| Normal-vs-AfricanAmerican |
5.775700E-04 |
| Normal-vs-Asian |
5.308300E-02 |
| Caucasian-vs-AfricanAmerican |
5.354000E-02 |
| Caucasian-vs-Asian |
2.907500E-02 |
| AfricanAmerican-vs-Asian |
3.307000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.170900E-04 |
| Normal-vs-Female |
1.55693999999151E-05 |
| Male-vs-Female |
7.954200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.140800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.54516999999466E-05 |
| Normal-vs-Age(61-80Yrs) |
1.784760E-03 |
| Normal-vs-Age(81-100Yrs) |
9.197500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.855800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.192800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.902000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.110410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.872200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.673600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.362400E-02 |
| Normal-vs-Grade 2 |
1.19659999997523E-06 |
| Normal-vs-Grade 3 |
6.562000E-03 |
| Normal-vs-Grade 4 |
1.192780E-01 |
| Grade 1-vs-Grade 2 |
1.194570E-01 |
| Grade 1-vs-Grade 3 |
8.047700E-02 |
| Grade 1-vs-Grade 4 |
1.406270E-02 |
| Grade 2-vs-Grade 3 |
2.623700E-02 |
| Grade 2-vs-Grade 4 |
6.270500E-02 |
| Grade 3-vs-Grade 4 |
7.043000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.71649999769485E-08 |
| Normal-vs-ccB subtype |
9.324300E-02 |
| ccA subtype-vs-ccB subtype |
2.580100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.380900E-03 |
| Normal-vs-N1 |
2.266000E-01 |
| N0-vs-N1 |
8.739000E-01 |
|
|
